Literature DB >> 3091137

Management of infection in the neutropenic patient.

R E Marcus, J M Goldman.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3091137      PMCID: PMC1341232          DOI: 10.1136/bmj.293.6544.406

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  19 in total

1.  Colonization resistance of the digestive tract of mice during systemic antibiotic treatment.

Authors:  D van der Waaij; J M Berghuis; J E Lekkerkerk
Journal:  J Hyg (Lond)       Date:  1972-12

2.  Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria.

Authors:  R G Graw; G Herzig; S Perry; E S Henderson
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

3.  Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction.

Authors:  R J O'Reilly; F K Lee; E Grossbard; N Kapoor; D Kirkpatrick; R Dinsmore; C Stutzer; K V Shah; A J Nahmias
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study.

Authors:  R H Herzig; G P Herzig; R G Graw; M I Bull; K K Ray
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

5.  Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

6.  Nosocomial infections in the immunocompromised adult.

Authors:  L S Young
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

7.  Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia.

Authors:  R M Lowenthal; L Grossman; J M Goldman; R A Storring; N A Buskard; D S Park; B C Murphy; A S Spiers; D A Galton
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

8.  Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.

Authors:  B E Murray; E R Rensimer; H L DuPont
Journal:  N Engl J Med       Date:  1982-01-21       Impact factor: 91.245

9.  Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.

Authors:  S C Schimpff; W H Greene; V M Young; C L Fortner; N Cusack; J B Block; P H Wiernik
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

10.  Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response.

Authors:  J Aisner; P H Wiernik; S C Schimpff
Journal:  Ann Intern Med       Date:  1977-05       Impact factor: 25.391

View more
  6 in total

1.  Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.

Authors:  A G Dewhurst; M J Cooper; S M Khan; A P Pallett; J R Dathan
Journal:  BMJ       Date:  1990-10-06

2.  Mycotic intracranial abscesses during induction treatment for acute lymphoblastic leukaemia.

Authors:  N K Foreman; M G Mott; T M Parkyn; G Moss
Journal:  Arch Dis Child       Date:  1988-04       Impact factor: 3.791

3.  Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.

Authors:  R Liang; R Yung; E Chiu; P Y Chau; T K Chan; W K Lam; D Todd
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Donor leucocyte imaging in patients with AIDS: a preliminary report.

Authors:  M J O'Doherty; P Revell; C J Page; S Lee; P J Mountford; T O Nunan
Journal:  Eur J Nucl Med       Date:  1990

5.  Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.

Authors:  R H Liang; R W Yung; T K Chan; P Y Chau; W K Lam; S Y So; D Todd
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Value of surveillance cultures in the management of neutropenic patients.

Authors:  M A Daw; P Munnelly; S R McCann; P A Daly; F R Falkiner; C T Keane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.